Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy
Clinical trial NCT03438279 · COMPLETED
Trial details
- NCT number
- NCT03438279
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-06-23
- Primary completion
- 2017-12-28
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.